Anebulo Pharmaceuticals Inc

NASDAQ:ANEB   2:57:07 PM EDT
6.82
+0.07 (+1.04%)
Earnings Announcements

Anebulo Pharmaceuticals Reports Q4 Loss Per Share Of $1.59

Published: 09/22/2021 20:20 GMT
Anebulo Pharmaceuticals Inc (ANEB) - Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Business Update.
Q4 Loss per Share $1.59.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.